Antisense peptide nucleic acid targeting GluR3 delays disease onset and progression in the SOD1 G93A mouse model of familial ALS.

Source:http://linkedlifedata.com/resource/pubmed/id/15264227

J. Neurosci. Res. 2004 Aug 15 77 4 573-82

Download in:

View as

General Info

PMID
15264227